文献速递消化、代谢与肾脏急症

巨噬细胞移动抑制因子对早期急性胰腺炎的影响

[Effects of macrophage migration inhibitory factor on early acute pancreatitis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论动物实验与临床观察显示,早期血清巨噬细胞移动抑制因子(MIF)在重症急性胰腺炎(SAP)中升高并与病情严重程度正相关,可能用于预测早期SAP。

该研究包含动物实验与临床观察两部分。动物实验将24只雄性SD大鼠分为假手术组及SAP 3、6、12小时组,经逆行胆胰管注射5%牛磺胆酸钠制备SAP模型,检测血清、肝、肾、肺、胰腺MIF水平。临床观察纳入72例急诊急性胰腺炎患者,按修订亚特兰大标准分为SAP组17例、MSAP组25例、MAP组30例,检测早期血清MIF并记录APACHE II评分。结果显示SAP大鼠血清、肝、胰腺MIF在造模后6小时达峰且高于假手术组,肺、肾MIF无显著差异;临床SAP、MSAP、MAP患者早期血清MIF依次降低,且各组MIF与APACHE II评分正相关。作者认为MIF可预测早期SAP的发生,并与早期AP严重程度相关。

要点

  • 临床观察中SAP、MSAP、MAP患者早期血清MIF依次为(14.83±2.99)、(10.17±2.64)、(7.21±2.47)μg/L,随病情严重程度递减。
  • SAP、MSAP、MAP各组血清MIF与同组APACHE II评分正相关(SAP:r=0.51,P=0.03;MSAP:r=0.45,P=0.02;MAP:r=0.45,P=0.01)。
  • SAP大鼠血清、肝、胰腺MIF在造模后6小时达峰,均显著高于假手术组(P<0.01),12小时仍高于假手术组。
  • SAP大鼠肺、肾MIF在造模后3、6、12小时与假手术组比较均无统计学显著差异。
  • 作者认为MIF可预测早期SAP的发生,并与早期AP严重程度相关。

适用人群与场景

  • 临床观察纳入18岁及以上、腹痛发作24小时内、血淀粉酶为正常水平3倍、临床诊断符合急性胰腺炎标准并收入郑州大学第一附属医院急诊科的患者,收治时间为2018年12月至2019年10月。
  • 动物实验使用雄性Sprague-Dawley(SD)大鼠24只。

诊断标准与关键阈值

  • 临床研究按修订亚特兰大标准将患者分为SAP组17例、MSAP组25例、MAP组30例。
  • 临床研究纳入条件包括腹痛发作24小时内、血淀粉酶为正常水平3倍、临床诊断符合急性胰腺炎标准。

处置流程与药物剂量

  • 动物实验经逆行胆胰管注射5%牛磺胆酸钠制备SAP大鼠模型。
  • 临床研究抽取静脉血,用酶联免疫吸附试验(ELISA)测定血清MIF水平,并记录24小时APACHE II评分。

研究设计与关键结果

  • 动物实验:24只雄性SD大鼠随机分为假手术组及SAP 3、6、12小时组,每组6只;SAP组血清、肝、胰腺MIF在造模后6小时达峰,与假手术组比较差异有统计学意义[血清MIF(ng/L):2 862.79±238.33 vs. 1 728.32±197.59;肝MIF(ng/L):2 141.39±328.07 vs. 1 372.70±163.41;胰腺MIF(ng/L):4 468.00±1 324.31 vs. 1 572.06±108.40,均P<0.01];造模后12小时血清、肝、胰腺MIF虽下降但仍显著高于假手术组;SAP大鼠肺、肾MIF在造模后3、6、12小时与假手术组比较均无统计学显著差异。
  • 临床观察:72例患者中SAP组17例、MSAP组25例、MAP组30例;早期血清MIF水平SAP、MSAP、MAP依次降低,分别为(14.83±2.99)、(10.17±2.64)、(7.21±2.47)μg/L;APACHE II评分亦依次降低,分别为10.41±3.74、7.60±3.18、4.00±2.41。
  • 相关分析:SAP、MSAP、MAP各组血清MIF水平与同组APACHE II评分呈正相关(SAP:r=0.51,P=0.03;MSAP:r=0.45,P=0.02;MAP:r=0.45,P=0.01)。

证据类型、等级与局限

  • 证据类型:动物实验联合临床观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为MIF可预测早期SAP的发生,并与早期AP严重程度相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the value of macrophage migration inhibitor factor (MIF) in early severe acute pancreatitis (SAP).

METHODS: (1) Animal experiment: according to the random number table method, 24 male Sprague-Dawley (SD) rats were divided into Sham group and SAP 3, 6 and 12 hours groups, with 6 rats in each group. SAP rat model was prepared by injecting 5% sodium taurocholate via the retrograde cholangiopancreatic duct. Liver, kidney, lung, pancreas and serum samples were harvested after 3, 6 and 12 hours. In the Sham group, tissue and serum were harvested immediately after pancreas was turned over. The histopathological changes of the pancreas were observed microscopically by hematoxylin-eosin (HE) staining. The MIF levels of serum, liver, kidney, lung and pancreas were measured by enzyme linked immunosorbent assay (ELISA). (2) Clinical study: an observational study was conducted. Seventy-two adult patients within 24 hours of the onset of abdominal pain (blood amylase was 3 times the normal level), and the clinical diagnosis met the criteria of acute pancreatitis (AP) admitted to the emergency department of the First Affiliated Hospital of Zhengzhou University from December 2018 to October 2019 were enrolled. Venous blood was extracted and serum MIF level was determined by ELISA. Acute physiology and chronic health evaluation II (APACHE II) was recorded for 24 hours. Patients were divided into SAP group (17 cases), moderate severe acute pancreatitis (MSAP) group (25 cases), and mild acute pancreatitis (MAP) group (30 cases) according to the revised Atlanta criteria for comparison between groups.

RESULTS: (1) The results of animal experiments showed that the serum, liver, and pancreatic MIF levels of rats in the SAP group all reached the peak at 6 hours after modeling, and the differences were statistically significant compared with the Sham group [serum MIF (ng/L): 2 862.79±238.33 vs. 1 728.32±197.59, liver MIF (ng/L): 2 141.39±328.07 vs. 1 372.70±163.41, pancreas MIF (ng/L): 4 468.00±1 324.31 vs. 1 572.06±108.40, all P < 0.01]; although the levels of MIF in serum, liver and pancreas decreased at 12 hours after modeling, they were still significantly higher than Sham group. However, there was no statistically significant difference in MIF levels of lung and kidney in SAP rats compared with Sham group at 3, 6 and 12 hours after molding. (2) Clinical observation showed that early serum MIF levels of SAP, MSAP and MAP patients decreased in order, (14.83±2.99), (10.17±2.64), and (7.21±2.47) μg/L, respectively; APACHE II scores also decreased in order, 10.41±3.74, 7.60±3.18 and 4.00±2.41 respectively. Correlation analysis showed that serum MIF levels in patients with SAP, MSAP, and MAP had a good correlation with APACHE II scores of the respective groups, showing that MIF levels was positively correlated with disease severity (SAP: r = 0.51, P = 0.03; MSAP: r = 0.45, P = 0.02; MAP: r = 0.45, P = 0.01).

CONCLUSIONS: MIF can predict the occurrence of early SAP, and it is related to the severity of early AP.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhu Z, Zheng X, Zhang L, et al. [Effects of macrophage migration inhibitory factor on early acute pancreatitis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32275010. doi:10.3760/cma.j.cn121430-20200113-00041

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。